Skip to content

Clinical trials

Withdrawn Phase 1/2 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Status: Withdrawn Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20072
20081
20101
20121
20141
20151
20161
20172
20181
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
National Cancer Institute (NCI)2
Chongqing Precision Biotech Co., Ltd1
H. Lee Moffitt Cancer Center and Research Institute1
Jonsson Comprehensive Cancer Center1
Masonic Cancer Center, University of Minnesota1
Oxford University Hospitals NHS Trust1
Shenzhen Geno-Immune Medical Institute1
University of Arkansas1
University of Maryland, Baltimore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms18
Carcinoma, Non-Small-Cell Lung9
Adenocarcinoma of Lung4
Breast Neoplasms3
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Neoplasm Metastasis2
Pancreatic Neoplasms2
Small Cell Lung Carcinoma2
Stomach Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.